Updated 10 November 2022
This was the first inspection of the service and was a routine, announced, inspection.
Updated 10 November 2022
This was the first inspection of the service and was a routine, announced, inspection.
Updated 10 November 2022
The Poundbury Cancer Centre opened in 2015 to provide quality analytical, interpretive, advisory and consultancy clinical cellular pathology.
The company provided a diagnostic service for histopathology specimens that included both surgically excised specimens and diagnostic biopsies. It provided standalone laboratory support for cellular pathology. This included a routine paraffin service, a comprehensive array of immunocytochemical and molecular tests with same day processing for
diagnostic tests and facilities for both onsite, and off-site reporting using digital pathology platforms.
The Centre focused particularly on the provision of tests for personalised oncology treatment, including companion diagnostics, to match a patient to a specific drug or therapy.
At the time of inspection, the service had achieved accreditation with the United Kingdom Accreditation Service and IS015189 for histopathological examination of human tissue for the purposes of clinical diagnosis.
The service employed one laboratory director, five in house pathologists and five pathologists who are contracted for remote working. One business development manager, reported as being externally contracted, one operations manager, two senior bio-medical scientist (BMS), six associated pathologists training for Institute of Biomedical Science (IBMS) registration portfolio, ten medical laboratory assistants and one administrator.
The service consists of two laboratory rooms and one administration room on a single floor. It did not offer a seven-day week service.
The service was regulated to provide Diagnostic and Screening procedures and there was a registered manager in post.
Following our inspection on 5 August 2022 we did not rate this service. This is because CQC does not apply a rating to independent laboratory services. We looked at four key questions: is the service safe, effective, responsive and well led. We did not inspect caring as the service does not have direct contact and interaction with patients.
We found that:
However
Updated 10 November 2022
We did not rate this service. See the summary above for what we found.
Systems, processes and standard operating procedures are not always reliable or appropriate to keep people safe.
We found that the service did not have adequate systems and processes in places to identify, monitor escalate and mitigate risk in the areas of fire prevention, recruitment, environmental safety for remote workers, and infection control. Governance processes did not reflect the risks of the service and in the absence of the quality manager information was difficult to obtain.